#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vaginal cancer Ocular lymphoma Squamous cell carcinoma of the hypopharynx Lupus nephritis Oesophageal adenocarcinoma Medullary thyroid cancer Cystic fibrosis Malignant melanoma Blood iron increased Liver transplant rejection Necrotising enterocolitis neonatal Hereditary spastic paraplegia Anaplastic large cell lymphoma T- and null-cell types Stevens-Johnson syndrome Breast angiosarcoma metastatic More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Diagnostics Synovial sarcoma metastatic – Treatment Chondrosarcoma – Basic Information Propionic acidaemia – Treatment Systemic sclerosis pulmonary – Diagnostics Activated PI3 kinase delta syndrome – Treatment Medulloblastoma – Basic Information Sarcoidosis – Basic Information Osteosarcoma – Basic Information Rhabdoid tumour – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ucp2 Treg02 Colchicine Belzupacap Sarotalocan Mps-106 Pertechnetate (99Mtc) Sodium Crd-4730 Pitavastatin Calcium Valbenazine Ditosylate Bi 1819479 Flupentixol Decanoate AAV9-CTNT-COBAG3 ANX007 Magnesium Hydroxide Pegenzileukin BW-20805 Lu Ag09222 Enasidenib Mesilate Aluminium Oxide RO7268489 More therapies…

    Learn about Your Condition

    Loeys-Dietz syndrome Cardiac arrest Head and neck cancer stage IV Pain in extremity Urticaria cholinergic Endocrine ophthalmopathy Hereditary optic atrophy Hepatic fibrosis Glomerulonephritis membranous Chorioretinitis Sleep disorder Biliary tract operation Papillary thyroid cancer Plasma cell myeloma recurrent Albright's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Idiopathic pulmonary fibrosis

  • A study to evaluate the effectiveness and safety of admilparant in patients with idiopathic pulmonary fibrosis

    Not yet recruiting

    3 1
    Investigated Drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • Study of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Tezepelumab
    Germany

  • Study on Inhaled Phospholipid Fraction from Bovine Lung for Patients with Idiopathic Pulmonary Fibrosis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Phospholipid Fraction, Bovine Lung
    Germany

  • Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • CAL101
    • Sodium Chloride
    Denmark France Italy The Netherlands Norway Romania +1

  • Study on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Drugs:
    • TALADEGIB
    Austria Belgium France Germany Ireland Italy

  • Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    • Pulmonary fibrosis
    Investigated Drugs:
    • Bi 1839100
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!